7 employees
Scala Biodesign offers partners a one-of-a-kind computational solution to drastically boost the value of proteins and accelerate.
$5.5M
from 3 investors over 3 rounds
Scala Biodesign raised $5.5M on September 11, 2023
Investors: TLV Partners and Intel Capital
Scala Biodesign raised undisclosed on November 9, 2022
Investors: Intel Ignite